Drugs for discoid lupus erythematosus
Información
- DOI:
- https://doi.org/10.1002/14651858.CD002954.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Piel
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
SJ :
Design of review, development of search strategy
MEDLINE search (part)
Retrieval and screening of studies
Writing to authors
Entering data
Interpretation (with co‐reviewer)
Writing review
DW:
Development of search strategy
Hand‐searching of index medicus
Electronic searching
Retrieval and screening of studies
Quality appraisal
Analysis and interpretation of data
Capturing of references to additional studies
FD:
Updating of the published review to the new format
Re‐analysing data
Updating search strategies and running searches
Sources of support
Internal sources
-
No support, South Africa.
-
Nottingham University, UK.
External sources
-
No sources of support supplied
Declarations of interest
There are no conflicts of interest.
Acknowledgements
This review was performed with the guidance and assistance of members of the Cochrane Skin Group, Nottingham, UK, in particular Hywel Williams, Finola Delamere, Tina Leonard, and Kayode Adetugbo.
The authors would like to acknowledge Francois Jordaan who was a co‐author on the original version of this review.
The editorial base would like to thank the following people who were the external referees for this review:
Mark Goodfield and Terence Ryan (content experts), and Maxine Whitton (consumer).
Version history
| Published | Title | Stage | Authors | Version |
| 2017 May 05 | Drugs for discoid lupus erythematosus | Review | Sue Jessop, David A Whitelaw, Matthew J Grainge, Prativa Jayasekera | |
| 2009 Oct 07 | Drugs for discoid lupus erythematosus | Review | Sue Jessop, David A Whitelaw, Finola M Delamere | |
| 2009 Jul 08 | Drugs for discoid lupus erythematosus | Review | Sue Jessop, Dave Whitelaw, Francois Jordaan | |
Differences between protocol and review
In the original review there were several changes compared to the published protocol:
Under 'Objectives' the sentence 'To identify the need for further study to make rational clinical decisions possible when treating cutaneous lupus' was omitted from the published review.
Under 'Primary Outcome Measures' we added 'percentage of people with' to our 'complete resolution of skin lesions' and 'clearing of erythema'.
Under 'Methods of the Review' the protocol addressed 'Quality rating of included studies', 'Main analyses' and 'Subgroup analysis' but these were shortened to 'Selection of studies' and 'Data extraction and management' in the published review.
In this 2009 updated version of the review:
The background section has been updated.
Under 'Types of interventions' the following interventions were added: biological agents, including infliximab, rituximab, etanercept, efalizumab, and topical calcineurin antagonists, including tacrolimus, pimecrolimus.
Under 'Search methods...' a section has been added entitled 'Adverse Effects'.
The 'Data collection and analysis' has been written in more detail.
The review has been amended to follow the RevMan recommended headings and the new Handbook guidelines.
